Mayo Clinic announced Wednesday that it has launched two new tech venture companies designed to harness artificial intelligence (AI) and medical algorithms and create “software as medical devices” that clinicians can use to improve treatment across different diseases.
The two new companies – Anumana Inc. and Lucem Health Inc. – were launched with a $30 million investment from the Mayo Clinic and its venture capital partners.
Anumana completed a $25.7 million Series A financing round, led by founding organizations nference and Mayo Clinic and in conjunction with Matrix Capital Management, Matrix Partners and NTTVC.